These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 23308041)

  • 1. Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders.
    Khanna R; Wilson SM; Brittain JM; Weimer J; Sultana R; Butterfield A; Hensley K
    Future Neurol; 2012 Nov; 7(6):749-771. PubMed ID: 23308041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protein interactome of collapsin response mediator protein-2 (CRMP2/DPYSL2) reveals novel partner proteins in brain tissue.
    Martins-de-Souza D; Cassoli JS; Nascimento JM; Hensley K; Guest PC; Pinzon-Velasco AM; Turck CW
    Proteomics Clin Appl; 2015 Oct; 9(9-10):817-31. PubMed ID: 25921334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of CRMP2 Post-Translational Modifications Drive Its Pathological Functions.
    Moutal A; White KA; Chefdeville A; Laufmann RN; Vitiello PF; Feinstein D; Weimer JM; Khanna R
    Mol Neurobiol; 2019 Oct; 56(10):6736-6755. PubMed ID: 30915713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of CRMP2 phosphorylation repairs CNS by regulating neurotrophic and inhibitory responses.
    Nagai J; Owada K; Kitamura Y; Goshima Y; Ohshima T
    Exp Neurol; 2016 Mar; 277():283-295. PubMed ID: 26795088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Druggability of CRMP2 for Neurodegenerative Diseases.
    Khanna R; Moutal A; Perez-Miller S; Chefdeville A; Boinon L; Patek M
    ACS Chem Neurosci; 2020 Sep; 11(17):2492-2505. PubMed ID: 32693579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRMP5 interacts with tubulin to inhibit neurite outgrowth, thereby modulating the function of CRMP2.
    Brot S; Rogemond V; Perrot V; Chounlamountri N; Auger C; Honnorat J; Moradi-Améli M
    J Neurosci; 2010 Aug; 30(32):10639-54. PubMed ID: 20702696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRMP2: functional roles in neural development and therapeutic potential in neurological diseases.
    Ip JP; Fu AK; Ip NY
    Neuroscientist; 2014 Dec; 20(6):589-98. PubMed ID: 24402611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The functionalized amino acid (S)-Lacosamide subverts CRMP2-mediated tubulin polymerization to prevent constitutive and activity-dependent increase in neurite outgrowth.
    Wilson SM; Moutal A; Melemedjian OK; Wang Y; Ju W; François-Moutal L; Khanna M; Khanna R
    Front Cell Neurosci; 2014; 8():196. PubMed ID: 25104922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinating Synaptic Signaling with CRMP2.
    Stratton H; Boinon L; Moutal A; Khanna R
    Int J Biochem Cell Biol; 2020 Jul; 124():105759. PubMed ID: 32437854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Insights into the Altering Function of CRMP2 by Phosphorylation.
    Sumi T; Imasaki T; Aoki M; Sakai N; Nitta E; Shirouzu M; Nitta R
    Cell Struct Funct; 2018; 43(1):15-23. PubMed ID: 29479005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5.
    Moutal A; François-Moutal L; Perez-Miller S; Cottier K; Chew LA; Yeon SK; Dai J; Park KD; Khanna M; Khanna R
    Mol Neurobiol; 2016 Apr; 53(3):1959-1976. PubMed ID: 25846820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing and nuclear localization of CRMP2 during brain development induce neurite outgrowth inhibition.
    Rogemond V; Auger C; Giraudon P; Becchi M; Auvergnon N; Belin MF; Honnorat J; Moradi-Améli M
    J Biol Chem; 2008 May; 283(21):14751-61. PubMed ID: 18332147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collapsin response mediator protein-2 plays a major protective role in acute axonal degeneration.
    Zhang JN; Koch JC
    Neural Regen Res; 2017 May; 12(5):692-695. PubMed ID: 28616018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteome and behavioral alterations in phosphorylation-deficient mutant Collapsin Response Mediator Protein2 knock-in mice.
    Nakamura H; Takahashi-Jitsuki A; Makihara H; Asano T; Kimura Y; Nakabayashi J; Yamashita N; Kawamoto Y; Nakamura F; Ohshima T; Hirano H; Tanaka F; Goshima Y
    Neurochem Int; 2018 Oct; 119():207-217. PubMed ID: 29758318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and expression pattern of human Unc-33-like phosphoprotein 6/collapsin response mediator protein 5 (Ulip6/CRMP5): coexistence with Ulip2/CRMP2 in Sema3a- sensitive oligodendrocytes.
    Ricard D; Rogemond V; Charrier E; Aguera M; Bagnard D; Belin MF; Thomasset N; Honnorat J
    J Neurosci; 2001 Sep; 21(18):7203-14. PubMed ID: 11549731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hierarchical CRMP2 posttranslational modifications control NaV1.7 function.
    Dustrude ET; Moutal A; Yang X; Wang Y; Khanna M; Khanna R
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):E8443-E8452. PubMed ID: 27940916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic identification of binding partners for the brain metabolite lanthionine ketimine (LK) and documentation of LK effects on microglia and motoneuron cell cultures.
    Hensley K; Christov A; Kamat S; Zhang XC; Jackson KW; Snow S; Post J
    J Neurosci; 2010 Feb; 30(8):2979-88. PubMed ID: 20181595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collapsin response mediator protein-2 (Crmp2) regulates trafficking by linking endocytic regulatory proteins to dynein motors.
    Rahajeng J; Giridharan SS; Naslavsky N; Caplan S
    J Biol Chem; 2010 Oct; 285(42):31918-22. PubMed ID: 20801876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications.
    Hensley K; Venkova K; Christov A; Gunning W; Park J
    Mol Neurobiol; 2011 Jun; 43(3):180-91. PubMed ID: 21271304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lanthionine ketimine ethyl ester partially rescues neurodevelopmental defects in unc-33 (DPYSL2/CRMP2) mutants.
    Hubbard C; Benda E; Hardin T; Baxter T; St John E; O'Brien S; Hensley K; Holgado AM
    J Neurosci Res; 2013 Sep; 91(9):1183-90. PubMed ID: 23825043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.